Biomimetic Neutrophil Nanotoxoids Elicit Potent Immunity against <i>Acinetobacter baumannii</i> in Multiple Models of Infection-Reference-Cited by-同舟云学术

Biomimetic Neutrophil Nanotoxoids Elicit Potent Immunity against Acinetobacter baumannii in Multiple Models of Infection

Published:2022-08-23 Issue:17 Volume:22 Page:7057-7065
ISSN:1530-6984
Container-title:Nano Letters
language:en
Short-container-title:Nano Lett.

Author:

Zhou Jiarong¹,Ventura Christian J.¹^ORCID,Yu Yiyan¹^ORCID,Gao Weiwei¹,Fang Ronnie H.¹,Zhang Liangfang¹^ORCID

Affiliation:

1. Department of NanoEngineering, Chemical Engineering Program, and Moores Cancer Center, University of California San Diego, La Jolla, California 92093, United States

Funder

National Institute of Allergy and Infectious Diseases

Defense Threat Reduction Agency

Publisher

American Chemical Society (ACS)

Subject

Mechanical Engineering,Condensed Matter Physics,General Materials Science,General Chemistry,Bioengineering

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.nanolett.2c01948

Reference56 articles.

1. Origins and Evolution of Antibiotic Resistance

2. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

3. Biology of Acinetobacter baumannii: Pathogenesis, Antibiotic Resistance Mechanisms, and Prospective Treatment Options

4. Virulence determinants and biofilm formation of Acinetobacter baumannii isolated from hospitalized patients

5. Development and Use of Personalized Bacteriophage-Based Therapeutic Cocktails To Treat a Patient with a Disseminated Resistant Acinetobacter baumannii Infection

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering cells or cellular outer membranes as multifaceted vehicles for reinforcing nanomedicine-based pulmonary disease treatment;Nano Today;2024-10

2. Multifaceted therapeutic applications of biomimetic nanovaccines;Drug Discovery Today;2024-06

3. Cell membrane-coated nanoparticles for targeting carcinogenic bacteria;Advanced Drug Delivery Reviews;2024-06

4. Recent Advances of Engineered Cell Membrane‐Based Nanotherapeutics to Combat Inflammatory Diseases;Small;2024-02-09

5. Single-dose of hybrid eukaryotic-prokaryotic nanovesicles to drive a rapid and controllable immune response against Klebsiella pneumoniae induced nosocomial pneumonia;Nano Today;2024-02